Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
acknowledges "clinical trials do show that they are effective for weight loss and weight maintenance," but notes that weight loss pills are usually only suggested for people with a body mass index ...